Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting

Biochemical Journal

Volumn 369, Issue 2, 2003, Pages 255-262

  Hersberger, Martin ^a,b   Patarroyo White, Susannah ^a   Qian, Xiaobing ^a   Arnold, Kay S ^a   Rohrer, Lucia ^b   Balestra, Maureen E ^a   Innerarity, Thomas L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cholesterol; Gene therapy; Tetracycline

Indexed keywords

CATALYSIS; ENZYMES;

HYPEREDITING;

BIOCHEMISTRY;

APOLIPOPROTEIN B; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; CYTIDINE DERIVATIVE; DOXYCYCLINE; MESSENGER RNA; POLYPEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CONTROLLED STUDY; DEAMINATION; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN TARGETING; RNA EDITING;

ANIMALS; APOLIPOPROTEINS B; CHOLESTEROL, LDL; CYTIDINE DEAMINASE; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LIVER; MICE; MICE, TRANSGENIC; RABBITS; RNA EDITING; TRANSGENES; TRIGLYCERIDES;

ORYCTOLAGUS CUNICULUS;

EID: 0037440117     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20020694     Document Type: Article

References (57)

1. Chan, L., Chang, B. H.-J., Nakamuta, M., Li, W.-H. and Smith, L. C. (1997) Apobec-1 and apolipoprotein B mRNA editing. Biochim. Biophys. Acta 1345, 11-26
2. Innerarity, T. L. (1991) The role of apolipoprotein E and apolipoprotein B in atherosclerosis. In Vascular Endothelium. Physiological Basis of Clinical Problems (Catravas, J. D., Callow, A. D., Gillis, C. N. and Ryan, U. S., eds.), pp. 183-196, Plenum Press, New York
3. Innerarity, T. L., Borén, J., Yamanaka, S. and Olofsson, S.-O. (1996) Biosynthesis of apolipoprotein B48-containing lipoproteins. Regulation by novel post-transcriptional mechanisms. J. Biol. Chem. 271, 2353-2356
4. Glickman, R. M., Rogers, M. and Glickman, J. N. (1986) Apolipoprotein B synthesis by human liver and intestine in vitro. Proc. Natl. Acad. Sci. U.S.A. 83, 5296-5300
5. Boström, K., Garcia, Z., Poksay, K. S., Johnson, D. F., Lusis, A. J. and Innerarity, T. L. (1990) Apolipoprotein B mRNA editing. Direct determination of the edited base and occurrence in non-apolipoprotein B-producing cell lines. J. Biol. Chem. 265, 22446-22452
6. Hodges, P. E., Navaratnam, N., Greeve, J. C. and Scott, J. (1991) Site-specific creation of uridine from cytidine in apolipoprotein B mRNA editing. Nucleic Acids Res. 19, 1197-1201
7. Johnson, D. F., Poksay, K. S. and Innerarity, T. L. (1993) The mechanism for apo-B mRNA editing is deamination. Biochem. Biophys. Res. Commun. 195, 1204-1210
8. Navaratnam, N., Shah, R., Patel, D., Fay, V. and Scott, J. (1993) Apolipoprotein B mRNA editing is associated with UV crosslinking of proteins to the editing site. Proc. Natl. Acad. Sci. U.S.A. 90, 222-226
9. Chen, S.-H., Habib, G., Yang, C.-Y., Gu, Z.-W., Lee, B. R., Weng, S.-A., Silberman, S. R., Cai, S.-J., Deslypere, J. P., Rosseneu, M., Gotto, Jr, A. M., Li, W.-H. and Chan, L. (1987) Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science 238, 363-366
10. Powell, L. M., Wallis, S. C., Pease, R. J., Edwards, Y. H., Knott, T. J. and Scott, J. (1987) A nover form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine. Cell 50, 831-840
11. Hersberger, M., Patarroyo-White, S., Arnold, K. S. and Innerarity, T. L. (1999) Phylogenetic analysis of the apolipoprotein B mRNA-editing region. Evidence for a secondary structure between the mooring sequence and the 3′ efficiency element. J. Biol. Chem. 274, 34590-34597
12. Richardson, N., Navaratnam, N. and Scott, J. (1998) Secondary structure for the apolipoprotein B mRNA editing site. AU-binding proteins interact with a stem loop. J. Biol. Chem. 273, 31707-31717
13. Borén, J., Lee, I., Zhu, W., Arnold, K., Taylor, S. and Innerarity, T. L. (1998) Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apoB-100. J. Clin. Invest. 101, 1084-1093
14. Farese, Jr, R. V., Cases, S., Ruland, S. L., Kayden, H. J., Wong, J. S., Young, S. G. and Hamilton, R. L. (1996) A novel function for apolipoprotein B: Lipoprotein synthesis in the yolk sac is critical for maternal-fetal lipid transport in mice. J. Lipid Res. 37, 347-360
15. Mahley, R. W. and Rall, Jr, S. C. (1995) Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of aporipoprotein E in normal and abnormal lipoprotein metabolism. In The Metabolic and Molecular Bases of Inherited Disease, 7th edn (Scriver, C. R, Beaudet, A. L., Sly, W. S. and Valle, D., eds.), pp. 1953-1980, McGraw-Hill, New York
16. Véniant, M. M., Zlot, C. H., Walzem, R. L., Pierotti, V., Driscorr, R., Dichek, D., Herz, J. and Young, S. G. (1998) Lipoprotein clearance mechanisms in LDL receptor-deficient "apoB-48-only" and "apoB-100-only" mice. J. Clin. Invest. 102, 1559-1568
17. Pitas, R. E., Innerarity, T. L. and Mahrey, R. W. (1980) Cell surface receptor binding of phospholipid-protein complexes containing different ratios of receptor-active and - inactive E apoprotein. J. Biol. Chem. 255, 5454-5460
18. Innerarity, T. L. and Mahley, R. W. (1978) Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with row density lipoproteins. Biochemistry 17, 1440-1447
19. Davidson, N. O., Innerarity, T. L., Scott, J., Smith, H., Driscoll, D. M., Teng, B. and Chan, L. (1995) Proposed nomenclature for the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme: APOBEC-1. RNA 1, 3
20. Teng, B., Burant, C. F. and Davidson, N. O. (1993) Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science 260, 1816-1819
21. Mehta, A., Kinter, M. T., Sherman, N. E. and Driscoll, D. M. (2000) Molecurar cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA Mol. Cell. Biol. 20, 1846-1854
22. Lellek, H., Kirsten, R., Diehl, I., Apostel, F., Buck, F. and Greeve, J. (2000) Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex. J. Biol. Chem. 275, 19848-19856
23. Lau, P. P., Zhu, H.-J., Nakamuta, M. and Chan, L. (1997) Cloning of an apobec-1-binding protein that also interacts with apolipoprotein B mRNA and evidence for its involvement in RNA editing. J. Biol. Chem. 272, 1452-1455
24. Greeve, J., Lellek, H., Rautenberg, P. and Greten, H. (1998) Inhibition of the apolipoprotein B mRNA editing enzyme-complex by hnRNP C1 protein and 40S hnRNP complexes. Biol. Chem. 379, 1063-1073
25. Navaratnam, N., Morrison, J. R., Bhattacharya, S., Patel, D., Funahashi, T., Giannoni, F., Teng, B.-B., Davidson, N. O. and Scott, J. (1993) The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase. J. Biol. Chem. 268, 20709-20712
26. Schock, D., Kuo, S.-R., Steinburg, M. F., Bolognino, M., Sparks, J. D., Sparks, C. E. and Smith, H. C. (1996) An auxiliary factor containing a 240-kDa protein complex is involved in apolipoprotein B RNA editing. Proc. Natl. Acad. Sci. U.S.A. 93, 1097-1102
27. Hughes, S. D., Rouy, D., Navaratnam, N., Scott, J. and Rubin, E. M. (1996) Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits. Hum. Gene Ther. 7, 39-49
28. Kozarsky, K. F., Bonen, D. K., Giannoni, F., Funahashi, T., Wilson, J. M. and Davidson, N. O. (1996) Hepatic expression of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (apobec-1) ameliorates hypercholesterolemia in LDL receptor-deficient rabbits. Hum. Gene Ther. 7, 943-957
29. Qian, X., Balestra, M. E., Yamanaka, S., Borén, J., Lee, I. and Innerarity, T. L. (1998) Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors. Arterioscler. Thromb. Vasc. Biol. 18, 1013-1020
30. Teng, B., Blumenthal, S., Forte, T., Navaratnam, N., Scott, J., Gotto, Jr, A. M. and Chart, L. (1994) Adenovirus-mediated gene transfer of rat apolipoprotein B mRNA-editing protein in mice virtually eliminates apolipoprotein B-100 and normal low density lipoprotein production. J. Biol. Chem. 269, 29395-29404
31. Teng, B., Ishida, B., Forte, T. M., Blumenthal, S., Song, L.-Z., Gotto, Jr, A. M. and Chart, L. (1997) Effective lowering of plasma, LDL, and esterified cholesterol in LDL receptor-knockout mice by adenovirus-mediated gene delivery of apoB mRNA editing enzyme (Apobec1). Arterioscler. Thromb. Vasc. Biol. 17, 889-897
32. Yamanaka, S., Balestra, M. E., Ferrell, L. D., Fan, J., Arnold, K. S., Taylor, S., Taylor, J. M. and Innerarity, T. L. (1995) Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc. Natl. Acad. Sci. U.S.A. 92, 8483-8487
33. Yamanaka, S., Poksay, K. S., Driscoll, D. M. and Innerarity, T. L. (1996) Hyperediting of multiple cytidines of apolipoprotein B mRNA by APDBEC-1 requires auxiliary protein(s) but not a mooring sequence motif. J. Biol. Chem. 271, 11506-11510
34. Yamanaka, S., Poksay, K. S., Arnold, K. S. and Innerarity, T. L. (1997) A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme. Genes Dev. 11, 321-333
35. Hersberger, M. and Innerarity, T. L. (1998) Two efficiency elements flanking the editing site of cytidine 6666 in the apolipoprotein B mRNA support mooring-dependent editing. J. Biol. Chem. 273, 9435-9442
36. Yamanaka, S., Poksay, K. S., Balestra, M. E., Zeng, G.-Q. and Innerarity, T. L. (1994) Cloning and mutagenesis of the rabbit apoB mRNA editing protein. A zinc motif is essential for catalytic activity, and noncatalytic auxiliary factor(s) of the editing complex are widely distributed. J. Biol. Chem. 269, 21725-21734
37. Gossen, M. and Bujard, H. (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U.S.A. 89, 5547-5551
38. Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W. and Buiard, H. (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766-1769
39. Kistner, A., Gossen, M., Zimmerman, F., Jerecic, J., Ullmer, C., Lübbert, H. and Bujard, H. (1996) Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice Proc. Natl. Acad. Sci. U.S.A. 93, 10933-10938
40. Fan, J., Wang, J., Bensadoun, A., Lauer, S. J., Dang, Q., Mahrey, R. W. and Taylor, J. M. (1994) Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc. Natl. Acad. Sci. U.S.A. 91, 8724-8728
41. Hersberger, M., Kirby, K., Phillips, J. P., Würgler, F. E., Koller, T. and Widmer, R. M. (1996) A plasmid rescue to investigate mutagenesis in transgenic D. melanogaster. Mutat. Res. 361, 165-172
42. Hirano, K.-I., Young, S. G., Farese, Jr, R. V., Ng, J., Sande, E., Warburton, C., Powell-Braxton, L. M. and Davidson, N. O. (1996) Targeted disruption of the mouse apobec-1 gene aborishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48. J. Biol. Chem. 271, 9887-9890
43. Horie, Y., Fazio, S., Westerlund, J. R., Weisgraber, K. H. and Rall, Jr, S. C. (1992) The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia. J. Biol. Chem. 267, 1962-1968
44. Breen, K., Schenker, S. and Heimberg, M. (1972) The effect of tetracycline on the hepatic secretion of triglyceride. Biochim. Biophys. Acta 270, 74-80
45. Estler, C.-J. and Böcker, R. (1980) Role of sex and age in the tetracycline-induced hepatic steatosis. Toxicol. Appl. Pharmacol. 54, 508-513
46. Böcker, R., Estler, C.-J., Maywald, M. and Weber, D. (1981) Comparative evaluation of the effects of tetracycline and doxycycline on blood and liver lipids of male and female mice. Arzneim Forsch. 31, 2118-2120
47. Sowden, M. P., Eagleton, M. J. and Smith, H. C. (1998) Apolipoprotein B RNA sequence 3′ of the mooring sequence and cellular sources of auxiliary factors determine the location and extent of promiscuous editing. Nucleic Acids Res. 26, 1644-1652
48. Sowden, M., Hamm, J. K. and Smith, H. C. (1996) Overexpression of APOBEC-1 results in mooring sequence-dependent promiscuous RNA editing. J. Biol. Chem. 271, 3011-3017
49. Lau, P. P., Xiong, W., Zhu, H.-J., Chen, S.-H. and Chan, L. (1991) Apolipoprotein B mRNA editing is an intranuclear event that occurs posttranscriptionally coincident with splicing and polyadenylation. J. Biol. Chem. 266, 20550-20554
50. Yang, Y., Yang, Y., Kovalski, K. and Smith, H. C. (1997) Partial characterization of the auxiliary factors involved in apolipoprotein B mRNA editing through APOBEC-1 affinity chromatography. J. Biol. Chem. 272, 27700-27706
51. Yang, Y., Sowden, M. P. and Smith, H. C. (2000) Induction of cytidine to uridine editing on cytoplasmic apolipoprotein B mRNA by overexpressing APOBEC-1. J. Biol. Chem. 275, 22663-22669
52. Siddiqui, J. F. M., Van Mater, D., Sowden, M. P. and Smith, H. C. (1999) Disproportionate relationship between APOBEC-1 expression and apolipoprotein B mRNA editing activity. Exp. Cell Res. 252, 154-164
53. Baum, C. L., Teng, B.-B. and Davidson, N. O. (1990) Apolipoprotein B messenger RNA editing in the rat liver. Modulation by fasting and refeeding a high carbohydrate diet. J. Biol. Chem. 265, 19263-19270
54. Davidson, N. O., Carlos, R. C., Drewek, M. J. and Parmer, T. G. (1988) Apolipoprotein gene expression in the rat is regulated in a tissue-specific manner by thyroid hormone. J. Lipid Res. 29, 1511-1522
55. Leighton, J. K., Joyner, J., Zamarripa, J., Deines, M. and Davis, R. A. (1990) Fasting decreases apolipoprotein B mRNA editing and the secretion of small molecular weight apoB by rat hepatocytes: Evidence that the total amount of apoB secreted is regulated post-transcriptionally. J. Lipid Res. 31, 1663-1668
56. Harris, S. G. and Smith, H. C. (1992) In vitro apotipoprotein B mRNA editing activity can be modulated by fasting and refeeding rats with a high carbohydrate diet. Biochem. Biophys. Res. Commun. 183, 899-903
57. Lau, P. P., Cahill, D. J., Zhu, H.-J. and Chan, L. (1995) Ethanol modulates apolipoprotein B mRNA editing in the rat. J. Lipid Res. 36, 2069-2078